Three-Day Dialysis Isn't Enough
Most kidney failure patients get dialysis treatment three times a week, often taking off the weekend. These two-day breaks may not be such a good idea.
Kidney Failure? Keep Treating Your Lupus
Lupus is a disease that can harm many parts of the body, and even end up causing kidney failure. Researchers have found a way to improve the survival of these patients.
Detecting Dialysis Risk
Doctors need to know which kidney disease patients are at risk for complications. Can they take action before those problems arise? The trouble is figuring out who is at risk. A specific hormone may be the sign.
The Color of Dialysis
For some time, studies have suggested that African-Americans do better on dialysis than whites. Such findings have affected practices guiding who gets kidney transplants. Now, those practices may need to change.
Small Scars for a Big Gift
Kidney transplants usually have a better chance of surviving if the organ comes from a living donor. With the number of living donor transplants on the rise, researchers are looking for ways to make the surgery easier on donors.
Seeing Sudden Death on Dialysis
When a diabetes patient's kidneys fail, that patient has to be put on dialysis. These patients may be at risk of having their heart suddenly stop. Now, researchers have found a way to spot who is most at risk.
Spotting the Silent Kidney Killer
The sooner kidney disease is spotted in a patient, the better chance that patient has of avoiding death. Now, there appears to be a way to detecting kidney disease even in those without signs of the disease.
What's the Best Cocktail for Transplants?
Even if a patient gets a new kidney, it is not the end of the fight against kidney disease. That patient's body can still reject the new organ. Now, researchers know which drugs work best to stop this from happening.
Staying Alive after a Kidney Transplant
Kidney disease patients can wait years before they get a transplant. Even when they get a new organ, their body might reject it. Now, there is a way to make patient's bodies more accepting of transplants.
FDA: Modified dosing recommendations for Erythropoiesis-Stimulating Agents
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals of modified recommendations for more conservative dosing of erythropoiesis-stimulating agents ( ESAs ) in patients with chronic kidney disease (CKD) to improve the safe use of these drugs.